Ani Pharmaceuticals (ANIP) Operating Margin (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Operating Margin of 16.38% for Q1 2026, up 16.37% sequentially from 14.07% in Q4 2025, and up 309.0% YoY from 4.0% in Q1 2025.
Ani Pharmaceuticals (ANIP) Operating Margin (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Operating Margin for 15 years, with the latest figure at 16.38% in Q1 2026.
- Quarterly Operating Margin rose 309.0% year-over-year to 16.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.4% (up 1244.0% YoY) and the FY2025 annual result came in at 12.58%, up 1248.0% from the prior year.
- Operating Margin advanced to 16.38% in Q1 2026 per ANIP's latest filing, from 14.07% in the prior quarter.
- Over five years, Operating Margin peaked at 16.38% in Q1 2026 and troughed at 29.77% in Q1 2022.
- A 5-year average of 3.29% and a median of 6.57% in 2025 frame the typical range for Operating Margin.
- The widest YoY moves for Operating Margin: up 4087 bps in 2022, down 5696 bps in 2022.
- Over 5 years, Operating Margin stood at 1.93% in 2022, then jumped by 165 bps to 5.11% in 2023, then sank by 145 bps to 2.3% in 2024, then surged by 713 bps to 14.07% in 2025, then rose by 16 bps to 16.38% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 16.38%, 14.07%, and 15.91% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 15.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.21% |
| Mar 31, 2026 | 16.38% |
| Dec 31, 2025 | 14.07% |
| Sep 30, 2025 | 15.91% |
| Jun 30, 2025 | 6.57% |
| Mar 31, 2025 | 13.29% |
| Dec 31, 2024 | -2.30% |
| Sep 30, 2024 | -13.83% |
| Jun 30, 2024 | 3.74% |
| Mar 31, 2024 | 14.78% |
| Dec 31, 2023 | 5.11% |
| Sep 30, 2023 | 13.61% |
| Jun 30, 2023 | 10.64% |
| Mar 31, 2023 | 9.27% |
| Dec 31, 2022 | 1.93% |
| Sep 30, 2022 | -5.96% |
| Jun 30, 2022 | -17.48% |
| Mar 31, 2022 | -29.77% |
| Dec 31, 2021 | -38.94% |
| Sep 30, 2021 | -6.84% |